<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The mutational activation of oncogenes drives <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development and progression </plain></SENT>
<SENT sid="1" pm="."><plain>Classic oncogenes, such as MYC and <z:mp ids='MP_0011356'>RAS</z:mp>, are active across many different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast, "lineage-survival" oncogenes represent a distinct and emerging class typically comprising transcriptional regulators of a specific cell lineage that, when deregulated, support the proliferation and survival of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> derived from that lineage </plain></SENT>
<SENT sid="3" pm="."><plain>Here, in a large collection of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, we identify recurrent amplification of chromosome 13, an alteration highly restricted to colorectal-derived <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>A minimal region of amplification on 13q12.2 pinpoints caudal type homeobox transcription factor 2 (CDX2), a regulator of <z:mpath ids='MPATH_458'>normal</z:mpath> intestinal lineage development and differentiation, as a target of the amplification </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast to its described role as a <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> suppressor, CDX2 when amplified is required for the proliferation and survival of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Further, transcriptional profiling, binding-site analysis, and functional studies link CDX2 to Wnt/Î²-catenin signaling, itself a key oncogenic pathway in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These data characterize CDX2 as a lineage-survival oncogene deregulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings challenge a prevailing view that CDX2 is a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and uncover an additional piece in the multistep model of colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>